STM
Journals
—
Open Access
Special Issue
Topic

Artificial Intelligence in Drug Delivery

Guest Editor:

        • Abstract Submission Deadline : 30/11/2023

        Manuscript Submission Deadline : 25/12/2023

        [This article belongs to Special Issue Artificial Intelligence in Drug Delivery under section rrjot, rrjot in (rrjot, rrjot)]

        Special Issue Description

        Interventional pharmacology is one of medicine’s strong weapons against diseases. These drugs, be that as they may, can result in harmful side impacts and must be closely observed. Pharmacovigilance is the field of science that screens recognizes, and avoids adverse drug reactions (ADRs). Security efforts start amid the advancement handle, utilizing in vivo and in vitro studies, proceed through clinical trials, and amplify to the postmarketing observation of ADRs in real-world populaces. The utilization of artificial intelligence (AI) has been expanding in different segments of society, especially the pharmaceutical industry. In this survey, we highlight the utilization of AI in different divisions of the pharmaceutical industry, counting medicate disclosure and advancement, drug repurposing, making strides in pharmaceutical efficiency, and clinical trials, among others; such utilization decreases the human workload as well as accomplishing targets in a brief period. With the consideration of AI within the manufacturing of pharmaceutical products, personalized drugs with the specified measurements, discharge parameters, and other required perspectives can be manufactured agreeing to patients’ needs required. Utilizing the most recent AI-based advances will not as it was speeding up the time required for the items to come to the advertising, but will too make strides in the quality of items and the general security of the production process, and give superior utilization of accessible assets alongside being cost-effective, subsequently expanding the significance of automation.

        Editor Keywords

        Adverse drug reactions (ADRs), Artificial Intelligence (AI), Drugs, Pharmaceutical, Diseases

        Manuscript Submission information

        Manuscripts should be submitted online by registering and logging in to this link. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed.
        Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent on email address:[email protected] for announcement on this website.

        Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page.

        Participating journals:

        Journal Name

        Research & Reviews: A Journal of Toxicology, Research & Reviews: A Journal of Toxicology

        Abbrivation

        rrjot, rrjot

        ISSN

        2231-3834, 2231-3834

        Since

        2010

        APC

        950  $